GRAIL, Inc.
GRAL- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001699031
In the last 90 days, GRAIL, Inc. insiders filed 0 open-market purchases and 4 sales; 375 institutions reported holding it in 13F filings for Q2 2026, worth $2.60B in total; no superinvestor holds it.
Members of Congress who traded GRAL
No member of Congress has reported a trade in GRAIL, Inc. since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.